a16z Capital Management, L.L.C. — 13F Holdings & Portfolio
CIK 1540358 · latest 13F-HR filed 2026-08-14
a16z Capital Management, L.L.C. manages $14.21B in 13F-reported U.S. long-equity assets across 19 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SPCX (89.97%), NAVN (4.54%), RVMD (1.21%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 4 new positions and exited 1; 7 existing positions rose in reported value and 4 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
| Name | Title / Status | Ownership | Type |
|---|
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- NAVAN INC$271.7M +72.7%
- REVOLUTION MEDICINES INC$82.9M +92.6%
- BIOAGE LABS INC$22.7M +40.1%
- BLOCK INC$16.1M +26.3%
- ERASCA INC$6.1M +13.2%
Top Trims
- FIGMA INC-$230.2M -68.0%
- NAUTILUS BIOTECHNOLOGY INC-$51.5M -75.3%
- OMADA HEALTH INC-$3.7M -12.7%
- BITGO HOLDINGS INC-$2.0M -37.1%
New Positions
- SPACE EXPLORATION TECHN CORP$12.79B
- ROBLOX CORP$14.9M
- KAILERA THERAPEUTICS INC$3.1M
- IP STRATEGY HOLDINGS INC$9.7K
a16z Capital Management, L.L.C. Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | SPACE EXPLORATION TECHN CORP | SPCX | 84615Q103 | $12.79B | 89.97% | 74,855,020 | SH |
| 2 | NAVAN INC | NAVN | 639193101 | $645.4M | 4.54% | 28,218,676 | SH |
| 3 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $172.5M | 1.21% | 921,099 | SH |
| 4 | META PLATFORMS INC | META | 30303M102 | $119.7M | 0.84% | 212,531 | SH |
| 5 | FIGMA INC | FIG | 316841105 | $108.2M | 0.76% | 5,983,308 | SH |
| 6 | BIOAGE LABS INC | BIOA | 09077V100 | $79.2M | 0.56% | 3,233,170 | SH |
| 7 | BLOCK INC | XYZ | 852234103 | $77.3M | 0.54% | 1,016,697 | SH |
| 8 | ERASCA INC | ERAS | 29479A108 | $52.4M | 0.37% | 2,862,500 | SH |
| 9 | MAZE THERAPEUTICS INC | MAZE | 578784100 | $50.8M | 0.36% | 1,702,225 | SH |
| 10 | DAMORA THERAPEUTICS INC | DMRA | 36322Q206 | $32.2M | 0.23% | 1,236,157 | SH |
| 11 | OMADA HEALTH INC | OMDA | 68170A108 | $25.3M | 0.18% | 1,153,639 | SH |
| 12 | NAUTILUS BIOTECHNOLOGY INC | NAUT | 63909J108 | $16.9M | 0.12% | 9,063,054 | SH |
| 13 | ROBLOX CORP | RBLX | 771049103 | $14.9M | 0.11% | 274,570 | SH |
| 14 | AKTIS ONCOLOGY INC | AKTS | 01021M104 | $13.4M | 0.09% | 415,000 | SH |
| 15 | CAMP4 THERAPEUTICS CORP | CAMP | 13463J101 | $9.3M | 0.07% | 2,125,339 | SH |
| 16 | BITGO HOLDINGS INC | BTGO | 091947101 | $3.5M | 0.02% | 666,356 | SH |
| 17 | KAILERA THERAPEUTICS INC | KLRA | 482931102 | $3.1M | 0.02% | 140,000 | SH |
| 18 | GINKGO BIOWORKS HOLDINGS INC | DNA | 37611X209 | $1.1M | 0.01% | 108,568 | SH |
| 19 | IP STRATEGY HOLDINGS INC | IPST | 42727R302 | $9.7K | 0.00% | 4,137 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $14.21B | 19 | 0001540358-26-000010 |
| 2026-03-31 | 2026-05-15 | $1.29B | 16 | 0001540358-26-000006 |
| 2025-12-31 | 2026-02-17 | $1.58B | 13 | 0001540358-26-000003 |
| 2025-09-30 | 2025-11-14 | $1.39B | 11 | 0001540358-25-000007 |
MENLO PARK, CA 94025